Cargando…

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer

Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-fre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez-Rodriguez, Rosa M., Patil, Sujata, Keshinro, Ajaratu, Shia, Jinru, Vakiani, Efsevia, Stadler, Zsofia, Segal, Neil H., Yaeger, Rona, Konishi, Tsuyoshi, Shimada, Yoshifumi, Widmar, Maria, Wei, Iris, Pappou, Emmanouil, Smith, J. Joshua, Nash, Garrett, Paty, Philip, Garcia-Aguilar, Julio, Weiser, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671050/
https://www.ncbi.nlm.nih.gov/pubmed/33235819
http://dx.doi.org/10.1080/2162402X.2020.1841948
_version_ 1783610854019694592
author Jimenez-Rodriguez, Rosa M.
Patil, Sujata
Keshinro, Ajaratu
Shia, Jinru
Vakiani, Efsevia
Stadler, Zsofia
Segal, Neil H.
Yaeger, Rona
Konishi, Tsuyoshi
Shimada, Yoshifumi
Widmar, Maria
Wei, Iris
Pappou, Emmanouil
Smith, J. Joshua
Nash, Garrett
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
author_facet Jimenez-Rodriguez, Rosa M.
Patil, Sujata
Keshinro, Ajaratu
Shia, Jinru
Vakiani, Efsevia
Stadler, Zsofia
Segal, Neil H.
Yaeger, Rona
Konishi, Tsuyoshi
Shimada, Yoshifumi
Widmar, Maria
Wei, Iris
Pappou, Emmanouil
Smith, J. Joshua
Nash, Garrett
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
author_sort Jimenez-Rodriguez, Rosa M.
collection PubMed
description Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-free survival (RFS) in 848 patients. Highest TIL in a single HPF was analyzed as a continuous and categorical variable, and optimal cutoff analysis was performed to predict RFS. Highest TIL count in a single HPF ranged from 0 to 45, and the optimal cutoff for TIL high vs TIL low was determined to be ≥ 3 vs < 3 with a concordance probability estimate of 0.74. In the entire cohort, 5-year RFS was 90.2% (95% CI = 83.7–94.2) in TIL high compared to 78.9% (95% CI = 74.1–82.9) in TIL low (log rank P < .0001). TIL remained significant in the mismatch repair-proficient (pMMR) cohort where 5-year RFS was 94.6% (95% CI = 88.3–97.5) in TIL high compared to 77.9% (95% CI = 69.2–84.4) in TIL low (P = .008). On multivariable analysis, TIL and AJCC Stage were independently associated with RFS in the pMMR cohort. Qualitatively in the pMMR cohort, RFS in Stage II TIL high patients was similar to that in Stage I patients and RFS in Stage III TIL high was similar to that in Stage II TIL low patients. Assessment of TIL in a single HPF using standard H&E slides provides important prognostic information independent of MMR status and AJCC stage.
format Online
Article
Text
id pubmed-7671050
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-76710502020-11-23 Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer Jimenez-Rodriguez, Rosa M. Patil, Sujata Keshinro, Ajaratu Shia, Jinru Vakiani, Efsevia Stadler, Zsofia Segal, Neil H. Yaeger, Rona Konishi, Tsuyoshi Shimada, Yoshifumi Widmar, Maria Wei, Iris Pappou, Emmanouil Smith, J. Joshua Nash, Garrett Paty, Philip Garcia-Aguilar, Julio Weiser, Martin R. Oncoimmunology Original Research Tumor infiltrating lymphocytes (TIL), which represent host adaptive response to the tumor, were first identified at scanning magnification to select areas with the highest counts on hematoxylin and eosin slides, quantitated per high-power field (HPF), and analyzed for association with recurrence-free survival (RFS) in 848 patients. Highest TIL in a single HPF was analyzed as a continuous and categorical variable, and optimal cutoff analysis was performed to predict RFS. Highest TIL count in a single HPF ranged from 0 to 45, and the optimal cutoff for TIL high vs TIL low was determined to be ≥ 3 vs < 3 with a concordance probability estimate of 0.74. In the entire cohort, 5-year RFS was 90.2% (95% CI = 83.7–94.2) in TIL high compared to 78.9% (95% CI = 74.1–82.9) in TIL low (log rank P < .0001). TIL remained significant in the mismatch repair-proficient (pMMR) cohort where 5-year RFS was 94.6% (95% CI = 88.3–97.5) in TIL high compared to 77.9% (95% CI = 69.2–84.4) in TIL low (P = .008). On multivariable analysis, TIL and AJCC Stage were independently associated with RFS in the pMMR cohort. Qualitatively in the pMMR cohort, RFS in Stage II TIL high patients was similar to that in Stage I patients and RFS in Stage III TIL high was similar to that in Stage II TIL low patients. Assessment of TIL in a single HPF using standard H&E slides provides important prognostic information independent of MMR status and AJCC stage. Taylor & Francis 2020-11-11 /pmc/articles/PMC7671050/ /pubmed/33235819 http://dx.doi.org/10.1080/2162402X.2020.1841948 Text en © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Jimenez-Rodriguez, Rosa M.
Patil, Sujata
Keshinro, Ajaratu
Shia, Jinru
Vakiani, Efsevia
Stadler, Zsofia
Segal, Neil H.
Yaeger, Rona
Konishi, Tsuyoshi
Shimada, Yoshifumi
Widmar, Maria
Wei, Iris
Pappou, Emmanouil
Smith, J. Joshua
Nash, Garrett
Paty, Philip
Garcia-Aguilar, Julio
Weiser, Martin R.
Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title_full Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title_fullStr Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title_full_unstemmed Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title_short Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
title_sort quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671050/
https://www.ncbi.nlm.nih.gov/pubmed/33235819
http://dx.doi.org/10.1080/2162402X.2020.1841948
work_keys_str_mv AT jimenezrodriguezrosam quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT patilsujata quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT keshinroajaratu quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT shiajinru quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT vakianiefsevia quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT stadlerzsofia quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT segalneilh quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT yaegerrona quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT konishitsuyoshi quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT shimadayoshifumi quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT widmarmaria quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT weiiris quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT pappouemmanouil quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT smithjjoshua quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT nashgarrett quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT patyphilip quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT garciaaguilarjulio quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer
AT weisermartinr quantitativeassessmentoftumorinfiltratinglymphocytesinmismatchrepairproficientcoloncancer